Document text
Principal Investigator: Richard B Kennedy
Organization: MAYO CLINIC ROCHESTER
Fiscal Year: 2020
Award: $786,112
Funding agency: National Institute of Allergy and Infectious Diseases
PROJECT SUMMARY/ABSTRACT
This application is a request for funding of a research program focused on understanding the factors associated with waning immune response to mumps vaccine. Waning immunity to mumps is a public health concern
and a major obstacle in the control and elimination of mumps disease. Outbreaks in the US and Europe primarily occur among highly vaccinated populations in their late teens and early twenties. These outbreaks are
primarily due to the waning of mumps vaccine-induced immunity. Waning immunity to mumps is defined by
decrease in antibody titer over time, decreased vaccine effectiveness in older subjects, and increased susceptibility to disease as time since vaccination increases; however, little information is available on the qualitative
characteristics of mumps-specific memory B cells, and even less data is available regarding long-term T cell
responses to mumps. Our goal is to study the first factor (decrease in immune responses over time). The establishment of long-lasting immunity to mumps is likely to be controlled by multiple immunologic pathways,
networks, and cell types acting in a coordinated and interactive manner. We propose to characterize B cell and
CD4+ T cell responses to a 3rd dose of MMR. We will then examine how baseline characteristics (e.g., prior Ab
response and sex) and genetic factors (mRNA and miRNA) influence those immune responses using a systems-biology approach and mediation analysis. In order to accomplish this objective, we propose the following
Specific Aims: 1) To conduct a systems biology study of early humoral (B cell) immune responses; 2) To conduct a systems biology study of early CD4+ T helper responses; and 3) To characterize interrelationships between T helper cell and humoral immune responses. These aims will allow us to comprehensively assess
how— and to what degree—baseline immunity, the early primary response to a 3rd dose of MMR, and the establishment of memory and return to homeostasis after MMR vaccination contribute to the observed clinical
waning of mumps immunity. In turn, this knowledge can be utilized to inform mechanistic studies of mumps
vaccine-induced immune persistence, develop more effective mumps vaccines and adjuvants in the future, and
to identify possible early biomarkers to detect those at greatest risk of waning protection against mumps.
Terms: <Adjuvant><Affect><Antibody Response><Antibody titer measurement><Autoregulation><B blood cells><B cell><B cells><B-Cells><B-Lymphocytes><B-cell><CD4 Cells><CD4 Positive T Lymphocytes><CD4 T cells><CD4 helper T cell><CD4 lymphocyte><CD4+ T-Lymphocyte><CD4-Positive Lymphocytes><Characteristics><Clinical><Cohort Studies><Concurrent Studies><Data><Disease><Disease Outbreaks><Disorder><Dose><ELISPOT><Epidemic Parotitis><Europe><Event><Funding><Future><Gamma interferon><Gene Expression><Generations><Genes><Genetic><Goals><Helper Cells><Helper T-Cells><Helper T-Lymphocytes><Helper-Inducer T-Cells><Helper-Inducer T-Lymphocyte><Homeostasis><Humoral Immunities><IFN-Gamma><IFN-g><IFN-γ><IFNG><IFNγ><Immune><Immune Interferon><Immune response><Immunes><Immunity><Immunization><Immunize><Immunochemical Immunologic><Immunologic><Immunologic Sensitization><Immunologic Stimulation><Immunological><Immunological Sensitization><Immunological Stimulation><Immunological response><Immunologically><Immunologics><Immunostimulation><Incidence><Inducer Cells><Inducer T-Lymphocytes><Infection><Interferon Gamma><Interferon Type II><Interferon-gamma><Knowledge><Longitudinal Studies><MMR Vaccine><Maintenance><Measles-Mumps-Rubella Vaccine><Mediating><Mediation><Memory><Memory B Cell><Memory B-Lymphocyte><Messenger RNA><Micro RNA><MicroRNAs><Molecular Fingerprinting><Molecular Profiling><Mumps><Negotiating><Negotiation><Outbreaks><Pathway interactions><Phenotype><Physiological Homeostasis><Population><Predisposition><Public Health><Research><Research Design><Risk><Sampling><Schedule><Science><Study Type><Susceptibility><Systems Biology><T cell response><T4 Cells><T4 Lymphocytes><Teen><Teenagers><Testing><Time><Vaccinated><Vaccination><Vaccines><Viral Vaccines><antibody titering><antibody-based immunity><authority><base><cell type><computer based prediction><cytokine><design><designing><early biomarkers><early detection biomarkers><early detection markers><enzyme linked immunospot assay><epidemic parotiditis><host response><human subject><immunoresponse><insight><intervention design><lFN-Gamma><long-term study><longitudinal outcome studies><longterm study><mRNA><miRNA><miRNAs><molecular profile><molecular signature><neutralizing antibody><pathway><prediction model><predictive modeling><prognostic model><programs><recruit><response><sex><study design><teen years><teenage><therapy design><treatment design><vaccine effectiveness><vaccine response><vaccine-induced immunity><vaccine-induced protection>